Actively Recruiting

Alzheimer's Disease Clinical Trials

Find recruiting clinical trials for Alzheimer's disease in the UK — including early onset, mild cognitive impairment (MCI), and APOE4+ subtypes. See treatment pathways and where trials fit in.

Free to use — Live data from ClinicalTrials.gov — Updated hourly

🎯 Smart Matcher — Find Trials For You

Answer a few questions about your condition and we'll match you to the most relevant clinical trials.

Find My Matches →

Alzheimer's Disease Treatment Pathway

See where clinical trials fit into your treatment journey

Prevention / MCI

Mild cognitive impairment or at-risk

Standard: Lifestyle interventions, anti-amyloid agents in trials

Early Alzheimer's

Mild symptoms, still independent

Standard: Cholinesterase inhibitors (Donepezil, Rivastigmine) + anti-amyloid therapy if eligible

Moderate

Increasing dependence on others

Standard: Add Memantine (Namenda), adjust cholinesterase inhibitor

Advanced

Significant care needs

Standard: Symptom management, behavioural strategies, or clinical trial

About Alzheimer's Disease

Early Onset

Alzheimer's diagnosed before age 65. Often has a stronger genetic component. About 5% of all Alzheimer's cases.

Mild Cognitive Impairment

Noticeable cognitive decline that does not yet interfere significantly with daily activities. Some people with MCI progress to Alzheimer's.

APOE4+

Carriers of the APOE4 gene variant have a higher risk of developing Alzheimer's. Many prevention trials specifically target this group.

Search Alzheimer's Disease Trials

Loading trials from ClinicalTrials.gov...

Frequently Asked Questions

Yes. Anti-amyloid therapies (Lecanemab, Donanemab) have shown significant promise in slowing disease progression. UK trials are also investigating anti-tau therapies, anti-inflammatory agents, and gene therapy approaches.

Absolutely. Many prevention and early intervention trials specifically target people with MCI. These trials aim to slow or prevent progression to Alzheimer's disease. Early participation is actively encouraged.

Most Alzheimer's trials include MRI or PET scans to monitor brain changes. Some may use amyloid PET scans or tau PET scans. These are provided at no cost to participants.

If the person lacks capacity to consent, a legally appointed representative (usually a family member with lasting power of attorney) can provide consent. The trial team will guide you through this process.

How to Join a Alzheimer's Disease Clinical Trial

1

Search

Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.

2

Discuss

Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.

3

Contact

Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.

4

Enrol

If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.

Related Comparisons

🗺️ Related Pathway: Neurological Pathway